Home › Kanser sa Bato (Renal Cell Carcinoma) › Michigan › Detroit

Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa Detroit, MI

Isang pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Nagre-recruitPhase 1

Research Site, Detroit
Research Site, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05536141

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Henry Ford Hospital, Detroit
Henry Ford Health Saint John Hospital, Detroit

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #65, Detroit
Exelixis Clinical Site #13, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Nagre-recruitPhase 2

Henry Ford Hospital, Detroit
Henry Ford Health Saint John Hospital, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

Nagre-recruitPhase 2

Henry Ford Health, Detroit

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07828704

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Nagre-recruitPhase 1/2

Henry Ford Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Nagre-recruitPhase 1/2

Henry Ford Health, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1

Henry Ford Health System, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT06026410

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Nagre-recruitPhase 1

Henry Ford Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05856981

A Beta-only IL-2 ImmunoTherapY Study

Nagre-recruitPhase 1/2

Karmanos Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa Detroit

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.